Fig. 4From: Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective studyKaplan–Meier curves for survival from BM diagnosis stratified by the use of OsimertinibBack to article page